| 1 | Mesenchymal stem cells and prostate cancer: A concise review of therapeutic potentials and biological aspects. 2022;63:102864 doi: 10.1016/j.scr.2022.102864 |
| 2 | Markers of malignant prostate cancer cells: Golgi localization of α-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface. 2020;527:406 doi: 10.1016/j.bbrc.2020.03.168 |
| 3 | Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target. 2020;8:569 doi: 10.3390/biomedicines8120569 |
| 4 | Engineering Prostate Cancer from Induced Pluripotent Stem Cells—New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies. 2020;21:905 doi: 10.3390/ijms21030905 |
| 5 | Human Cell Transformation. 2019;1164:109 doi: 10.1007/978-3-030-22254-3_9 |
| 6 | Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer Tissue. 2022;9: doi: 10.3389/fmolb.2022.878353 |
| 7 | Addressing cancer invasion and cell motility with quantitative light microscopy. 2022;12: doi: 10.1038/s41598-022-05307-7 |
| 8 | Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance. 2019;20:2437 doi: 10.3390/ijms20102437 |
| 9 | ; ; ; doi: |
| 10 | Biological Adaptations of Tumor Cells to Radiation Therapy. 2021;11: doi: 10.3389/fonc.2021.718636 |
| 11 | Cancer nanotechnology: current status and perspectives. 2021;8: doi: 10.1186/s40580-021-00282-7 |
Journal of Cancer Metastasis and Treatment
